(Q44352589)

2 December 2017

title

Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine (English)

1 reference

2 December 2017

0 references

0 references

K R Powell

1

1 reference

2 December 2017

S G Holtzman

series ordinal

2

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

European Journal of Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

377

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

21-28

1 reference

Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Lack of cross-tolerance between U69,593 and bremazocine suggests kappa-opioid receptor multiplicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Behavioral effects of systemically administered mu and kappa opioid agonists in the squirrel monkey: peptides versus alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

[3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Discriminative stimulus and response rate-decreasing effects of kappa opioids: antagonism by naloxone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Bremazocine: A potent, long-acting opiate kappa-agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

pA2 and receptor differentiation: a statistical analysis of competitive antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900394-5

10.1016/S0014-2999(99)00394-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference